Related Experiment Video
Updated: Jul 7, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
AlphaMbeta2 integrin modulator exerts antitumor activity in vivo
Juho Suojanen1, Tuula Salo, Timo Sorsa
1Department of Oral and Maxillofacial Diseases, Helsinki University Central Hospital, Institute of Dentistry, University of Helsinki, FI-00014, Finland. juho.suojanen@helsinki.fi
The novel small molecule IMB-10 effectively targets leukocyte alphaMbeta2 integrin, inhibiting the growth of lymphoma and leukemia xenografts. This immunomodulatory therapy also reduced tumor-infiltrating leukocytes and impacted squamous cell carcinoma invasion.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Leukocyte immunomodulation offers significant clinical potential for treating inflammatory diseases and cancer.
- A novel small molecule, IMB-10, has been developed to target leukocyte alphaMbeta2 integrin, inhibiting leukocyte migration and recruitment.
- This molecule demonstrates potential for therapeutic applications in various diseases.
Purpose of the Study:
- To evaluate the anticancer effects of IMB-10.
- To investigate the efficacy of IMB-10 in preclinical models of lymphoma, leukemia, and squamous cell carcinoma.
- To assess the impact of IMB-10 on host leukocyte infiltration and tumor invasion.
Main Methods:
- Utilized U937 histiocytic lymphoma, OCI-AML-3 acute myeloid leukemia, and HSC-3 tongue squamous cell carcinoma xenografts.
- Employed athymic nude mice lacking T-lymphocytes to model tumor growth and response to IMB-10.
- Quantified xenograft growth inhibition, survival rates, and leukocyte infiltration.
Main Results:
- IMB-10 therapy significantly inhibited the growth of both leukemia and lymphoma xenografts.
- Treatment with IMB-10 notably prolonged the survival of mice bearing lymphoma xenografts.
- IMB-10 reduced host leukocyte infiltration within tumors and affected the invasive capacity of squamous cell carcinomas.
Conclusions:
- IMB-10 shows therapeutic promise for leukocytic malignancies, particularly lymphomas.
- The molecule's ability to inhibit carcinoma invasion suggests a role in modulating host inflammation's effect on tumor progression.
- These findings indicate that IMB-10 may impact tumor progression via T-cell independent mechanisms involving inflammation.
More Related Videos
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.

